Nick James
Nick James is a prominent cancer researcher and professor at the Institute of Cancer Research (ICR) in England. He has contributed significantly to the understanding of prostate cancer, particularly in relation to its increasing incidence due to an aging population. In recent discussions, he has emphasized the need for healthcare systems to adapt to the rising number of older individuals at risk for this disease.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 9.00 | 0.04% | +0% | 67,886,011 | 28,286 | $2,700,000 | 1,125$ |
| Totals | 1 | 67,886,011 | 28,286 | $2,700,000 | 1,125$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Nick James co-led the team that built the AI test to predict which men with prostate cancer would benefit from abiraterone.
9
Liechtenstein:
Nick James is one of the authors of the analysis discussing the increase in prostate cancer cases due to an aging population.
7